Business

HPQ Silicon Closed over $1.0 Million Non-Brokered Private Placement

MONTREAL, Dec. 15, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the ...

articleHpq Silicon IncDecember 15, 20255/company/hpq-silicon-resources-inc/news/hpq-silicon-closed-over-dollar10-million-non-brokered-private-placement
HPQ Silicon Closed over $1.0 Million Non-Brokered Private Placement

About this update from Hpq Silicon Inc

[{"type":"text","content":"HPQ Silicon Closed over $1.0 Million Non-Brokered Private PlacementNew Funding will help advance the commercialization of core technology platforms\n\n\n\n MONTREAL, Dec. 15, 2025 (GLOBE NEWSWIRE) --\n \n\n HPQ Silicon Inc.\n \n\n (“HPQ” or the “Company”) (TSX-V:\n \n HPQ\n \n , OTCQB:\n \n HPQFF\n \n , FRA:\n \n O08\n \n ), a technology company driving innovation in advanced materials and critical process development, announced that it has closed a non-brokered private placement of 6,170,442 common shares at a price of $0.1625 per share, for gross proceeds of $1,002,696.83.\n \n\n All securities issued under the private placement are subject to a statutory hold period of four months and one day from the closing date of the placement, in accordance with applicable Canadian securities laws. The placement remains subject to final acceptance by the TSX Venture Exchange.\n \n\n In connection with the private placement, HPQ will pay commissions by issuing 333,303 warrants to CI Investment Services Inc. Each warrant entitles the agent to purchase one common share at an exercise price of $0.18 per share for a period of 48 months from the closing date of the placement, subject to the same four-month-and-one-day hold period.\n \n\n\n Use of proceeds:\n \n\n\n In addition to general working capital and corporate purposes, the net proceeds from the financing will be strategically deployed to advance HPQ’s commercialization initiatives across its three core technology pillars:\n \n\n\n\n Fumed Silica Reactor (FSR):\n \n focus on client-driven commercial scale-up opportunities and revenue generations pathways;\n \n\n\n HPQ ENDURA+™\n \n : commercialization of HPQ ENDURA+™ cells and advancement of the NRCan-supported silicon-based anode material program;\n \n\n\n METAGENE™\n \n : continue technology development and commercialization of the autonomous green hydrogen production platform.\n \n\n\n\n\n Management Participation:\n \n\n\n As part of the financing, Mr. Bernard Tourillon, Chairman, President, CEO, and Director, insider and related party of HPQ, directly or through entities under his control, subscribed for 615,384 common shares ($99,999.90). Following the closing of the private placement, Mr. Tourillon beneficially owns or controls, directly or indirectly, 22,796,794 common shar...

More updates from Hpq Silicon Inc